Treace Medical Concepts, Inc. TMCI Payments Of Debt Issuance Costs

Payments Of Debt Issuance Costs at other companies

Zimmer Biomet HoldingsZBH

——

Orthofix Medical Inc.OFIX

——

Xtant Medical HoldingsXTNT

——

Other financials

Income statement

See full

Revenue$47.2M-10.2%

Gross profit$37.4M-10.7%

Operating income-$17.2M-10.2%

Net income-$18.0M-12.8%

EPS (diluted)-$0.28-12.0%

Balance sheet

See full

Cash & equivalents$9.5M-28.6%

Total debt$71.6M+3.2%

Total equity$77.2M-26.7%

Total assets$184.1M-10.6%

Cash flow

See full

Operating cash flow$7.2M+72.5%

CapEx$3.1M-13.6%

Free cash flow$4.2M+538%

Valuation

See full

Market cap$258.19M-26.6%

Enterprise value$320.25M-22.6%

P/S1.3×-0.4×

Profitability

See full

Gross margin79.7%-0.5pp

Operating margin-26.9%+2.5pp

Net margin-29.4%+6.1pp

FCF margin-12.5%-2.8pp

Returns & leverage

See full

Return on equity-66.9%+57.5pp

Debt / equity0.9×+0.3×

Current ratio3.6×-0.9×

Where this comes from

Reported directly by Treace Medical Concepts, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Treace Medical Concepts, Inc.'s payments of debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Treace Medical Concepts, Inc.'s payments of debt issuance costs?: Treace Medical Concepts, Inc. (TMCI) reported payments of debt issuance costs of $6K in Q1 2026.